Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS
西格列汀并不能降低糖尿病患者心肌梗死后发生心血管死亡或因心力衰竭住院的风险：TECOS 研究的观察结果
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-019-0921-2
Nauck, Michael A; McGuire, Darren K; Pieper, Karen S; Lokhnygina, Yuliya; Strandberg, Timo E; Riefflin, Axel; Delibasi, Tuncay; Peterson, Eric D; White, Harvey D; Scott, Russell; Holman, Rury R
